Marshall Wace, LLP KYVERNA THERAPEU Transaction History

Marshall Wace, LLP

  • $81.7 Billion
  • Q2 2025
Number of Shares
62,057
Previous 24,561 152.66%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
N/A
37,496 Added 152.66%
62,057 $0
Q1 2025

May 15, 2025
BUY
N/A
9,320 Added 61.15%
24,561 $0
Q4 2024

Feb 13, 2025
SELL
N/A
-16,982 Reduced 52.7%
15,241 $0
Q3 2024

Nov 14, 2024
BUY
N/A
21,823 Added 209.84%
32,223 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-145,355 Reduced 93.32%
10,400 $0
Q1 2024

May 15, 2024
BUY
N/A
155,755 New
155,755 $0
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email